Cytokinetics CYTK Operating margin

Operating margin at other companies

Lexicon PharmaceuticalsLXRX

-131.4%-34.2pp

Capricor TherapeuticsCAPR

-778.8%-1,038pp

Kiniksa Pharmaceuticals International, plcKNSA

11.9%+11.1pp

iRhythm Holdings, Inc.IRTC

-3.3%-1.5pp

MannkindMNKD

23.3%+3.1pp

Boston ScientificBSX

19.8%+2.8pp

FAQ

What is Cytokinetics's operating margin?

Cytokinetics (CYTK) reported operating margin of -1,046.1% in Q2 2026.

How has Cytokinetics's operating margin changed year-over-year?

Cytokinetics's operating margin decreased by 64.0% year-over-year, from -638% to -1,046.1%.

What is the long-term trend for Cytokinetics's operating margin?

Over 5 years (2020 to 2025), Cytokinetics's operating margin has grown at a 32.8% compound annual growth rate (CAGR), from -168.3% to -695.4%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.